Vice President, Medical - IBD

🕒 July 28

🇨🇭 Switzerland – Remote

⏰ Full Time

🔴 Lead

👔 Vice President

👻 Ghost score 18%

What it means: how likely this posting is sitting open without active hiring.How to read it: 60% or higher means we think this is a ghost. Lower scores are less of a worry.How we score it: age, reposts, open roles vs team size, how fast jobs close, and whether pay is listed.Fine print: an estimate from public data, not a judgment of the company. Real jobs can score high, so treat it as a hint, not a fact.

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Numab Therapeutics AG

WebsiteLinkedInAll Job Openings

51 - 200 employees

Founded 2011

🧬 Biotechnology

💊 Pharmaceuticals

💰 $54.9M Series C - Numab on 2025-01

Biotechnology • Pharmaceuticals

Numab Therapeutics AG is a Swiss biotechnology company based in Horgen that discovers and develops next-generation multispecific antibody-based therapeutics for immunology and immuno-oncology. Numab uses proprietary discovery and engineering platforms (λ-Cap™ and MATCH™) to design plug-and-play multispecific molecules intended to improve potency, stability, pharmacokinetics, duration of effect, and safety versus first-generation antibodies. The company advances an in-house pipeline and collaborates with pharmaceutical partners (e. g. , Boehringer Ingelheim, Kaken Pharmaceutical) to co-develop and license multispecific antibody candidates for diseases including inflammatory bowel disease and retinal and tumor indications.

📋 Description

• The Vice President, Medical will play a dual role spanning Clinical Development and Medical Affairs. • Internally, they will provide medical leadership for the ongoing development of Numab's IBD programme, contributing to clinical strategy, trial design, data interpretation, and development planning. • A key focus will be helping shape the design of early phase studies in patients and identifying innovative approaches that maximize the opportunity to demonstrate meaningful clinical differentiation in a competitive therapeutic landscape. • Externally, they will establish and maintain trusted relationships with leading experts in IBD and related fields, helping ensure that Numab's science, data, and therapeutic approach are understood within the broader context of disease biology and evolving treatment paradigms. • The individual will serve as a credible scientific ambassador for the company and play an important role in shaping external scientific dialogue surrounding both the programme and the future role of tri-specific antibodies in IBD.

🎯 Requirements

• MD or equivalent medical qualification. • Significant experience within biotechnology or pharmaceutical drug development. • Deep expertise in inflammatory bowel disease, with an established reputation and network within the IBD community. • Experience spanning both Medical Affairs and Clinical Development. • Strong understanding of inflammatory pathways, disease pathophysiology, biologic therapies, and evolving treatment approaches in IBD. • Demonstrated experience contributing to clinical study design, development strategy, and interpretation of clinical data. • Proven ability to engage and influence scientific discussions with external experts through credible, evidence-based scientific exchange.

🏖️ Benefits

• Please note that applications that do not meet the requirements will not be considered.